Dr Su Metcalfe is sitting quietly reading through some documents in the lobby of the Judge Business School when I arrive for our interview. It would be easy to walk right past her and not know you were in the presence of a woman who could be on the verge of curing multiple sclerosis.
MS, an auto-immune condition which affects 2.3 million people around the world, attacks cells in the brain and the spinal cord, causing an array of physical and mental side effects including blindness and muscle weakness. At the moment there’s no cure, but Su and her company, LIFNano, hope to change that.
Patients volunteer for pioneering treatment by Cambridge scientist on verge of curing multiple sclerosis
“Some people get progressive MS, so go straight to the severe form of the disease, but the majority have a relapsing or remitting version,” she says.
“It can start from the age of …
READ MORE ON CAMBRIDGE-NEWS.CO.UK